TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33667525

Group type: EXPERIMENTAL
Intervention: TAS-102 (trifluorothymidine and tipiracil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAS-102
Number of subjects: 0
Study: 32093742

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) monotherapy at a dosage of 0.05-0.1 mg/kg/day for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide (CTX) combined with glucocorticoid
Number of subjects: 0
Study: 35256183

Group type: EXPERIMENTAL
Intervention: Simplified complete dentures
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 40
Study: 35902197

Group type: EXPERIMENTAL
Intervention: Vitrectomy combined with lens capsule flap transplantation
Number of subjects: 54

Group type: COMPARATOR
Intervention: ILM tamponade
Number of subjects: 54
Study: 33765241

Group type: EXPERIMENTAL
Intervention: Inpatient Multimodal Occupational Rehabilitation (I‐MORE)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Outpatient Acceptance and Commitment Therapy (O‐ACT)
Number of subjects: 166
Study: 32173882

Group type: EXPERIMENTAL
Intervention: Single-plane MFU-V treatment (4.5 mm)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dual-plane MFU-V treatment (4.5 and 3.0 mm)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study: 35086362

Group type: EXPERIMENTAL
Intervention: IVH expansion
Number of subjects: 500
Study: 34166799

Group type: EXPERIMENTAL
Intervention: History of depression
Number of subjects: 894
Study: 35477884

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) and anorganic bovine bone mineral (ABBM) complex with collagen membrane
Number of subjects: 16

Group type: COMPARATOR
Intervention: Anorganic bovine bone mineral (ABBM) with collagen membrane
Number of subjects: 16
Study: 34694869

Group type: EXPERIMENTAL
Intervention: Capsaicin nebulization
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 63
Study: 35783511

Group type: EXPERIMENTAL
Intervention: honey and fenugreek
Number of subjects: 75

Group type: COMPARATOR
Intervention: fenugreek
Number of subjects: 75
Study: 32345286

Group type: EXPERIMENTAL
Intervention: Guided counseling using the health belief model and the theory of planned behavior; 4 counseling sessions before 16 weeks of gestation
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Guided counseling using the health belief model and the theory of planned behavior
Number of subjects: 694

Group type: COMPARATOR
Intervention: Routine nutrition education provided by the health care system (Control)
Number of subjects: 694
Study: 33780315

Group type: EXPERIMENTAL
Intervention: Straight and fast injection
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Straight and slow injection
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Tunneled and fast injection
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Tunneled and slow injection
Number of subjects: 180
Study: 32211800

Group type: EXPERIMENTAL
Intervention: Thiamin fortification
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Milk nutrient concentrations
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 68
Study: 33835354

Group type: EXPERIMENTAL
Intervention: Surviving and Thriving in the Real World (STRW) intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Entire sample analyses with 10 participants
Number of subjects: 12

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 12
Study: 34707012

Group type: EXPERIMENTAL
Intervention: BOLD-MRI-based radiomics
Number of subjects: 141
Study: 35906051

Group type: EXPERIMENTAL
Intervention: Eccentric training for 6 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Concentric training for 6 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Asymptomatic controls
Number of subjects: 26
Study: 33987636

Group type: EXPERIMENTAL
Intervention: Switch ART (n=4166)
Number of subjects: 7316

Group type: COMPARATOR
Intervention: Stable Baseline Regimen (SBR) (n=3150)
Number of subjects: 7316

Group type: EXPERIMENTAL
Intervention: Switch from efavirenz (EFV) to rilpivirine (RPV) or elvitegravir/cobicistat
Number of subjects: 7316

Group type: EXPERIMENTAL
Intervention: Switch from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)
Number of subjects: 7316

Group type: EXPERIMENTAL
Intervention: Switch from abacavir to TAF
Number of subjects: 7316
Study: 33934514

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with midazolam (DEX group)
Number of subjects: 433
Study: 32330093

Group type: EXPERIMENTAL
Intervention: Graded standing exposure and exercise (intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sit-stand desk use (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No instruction (control)
Number of subjects: 0
Study: 35012439

Group type: EXPERIMENTAL
Intervention: Individual cognitive stimulation (iCS) - 47 weekly sessions
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group - maintained baseline treatments
Number of subjects: 59
Study: 35616194

Group type: EXPERIMENTAL
Intervention: Two-finger technique (TFT) with real-time visual feedback (RVF)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: One-hand technique (OHT) without RVF
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: One-hand technique (OHT) with RVF
Number of subjects: 59
Study: 33371066

Group type: EXPERIMENTAL
Intervention: Nursing intervention based on quantitative evaluation
Number of subjects: 50
Study: 35788765

Group type: EXPERIMENTAL
Intervention: Culture-specific, motivated, action-based intervention in addition to usual care
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 32964773

Group type: EXPERIMENTAL
Intervention: Teleaudiology follow-up consultation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard face-to-face follow-up consultation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Blended services
Number of subjects: 56
Study: 33979096

Group type: EXPERIMENTAL
Intervention: VCP immunoreactivity in lesional psoriatic sections
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Epidermal VCP H-score
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: VCP expression in the dermis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Higher VCP in the dermis
Number of subjects: 25
Study: 33376746

Group type: EXPERIMENTAL
Intervention: AE‐IPF risk prediction model based on history of occupational exposure, diabetes mellitus (DM), essential hypertension (EH), and diffusion capacity for carbon monoxide (DLCO)% predicted.
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: AE‐IPF risk prediction model
Number of subjects: 110
Study: 36192617

Group type: EXPERIMENTAL
Intervention: Letrozole 5 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control (no added treatment)
Number of subjects: 123
Study: 33779741

Group type: EXPERIMENTAL
Intervention: Internet search for health information
Number of subjects: 5000
Study: 34251536

Group type: EXPERIMENTAL
Intervention: TTO NE + ADA Gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: ADA Marketed Gel
Number of subjects: 100
Study: 34543460

Group type: EXPERIMENTAL
Intervention: Resorbable collagen membranes (BG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nonresorbable ePTFE membranes (GT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Implants placed in pristine bone (CT)
Number of subjects: 39
Study: 35259925

Group type: EXPERIMENTAL
Intervention: Thiazide-type diuretics
Number of subjects: 9252

Group type: EXPERIMENTAL
Intervention: Renin-angiotensin system blockers
Number of subjects: 9252

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 9252

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 9252

Group type: EXPERIMENTAL
Intervention: Thiazide-type diuretics and renin-angiotensin system blockers
Number of subjects: 9252
Study: 35051663

Group type: EXPERIMENTAL
Intervention: aPDT (antimicrobial photodynamic therapy) using a curcumin-based photosensitizer, exposed to 660 nm light for 5 minutes at 200 J/cm2 fluency.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham aPDT (non-activated laser tip).
Number of subjects: 46
Study: 35333743

Group type: EXPERIMENTAL
Intervention: Trazodone (9 to 12 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32197631

Group type: EXPERIMENTAL
Intervention: Educational training for GPs promoting a deprescribing guideline and conducting family conferences.
Number of subjects: 676

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 676
Study: 34534319

Group type: EXPERIMENTAL
Intervention: Preseason HAI antibody titers
Number of subjects: 5180

Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 5180
Study: 35871010

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT) with pre-treatment assessment interview
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT) with guidance
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT) with both pre-treatment assessment interview and guidance
Number of subjects: 270

Group type: COMPARATOR
Intervention: Internet-delivered cognitive behavioral therapy (ICBT) with neither pre-treatment assessment interview nor guidance
Number of subjects: 270
Study: 32164723

Group type: EXPERIMENTAL
Intervention: Guided Internet- and mobile-based cognitive behavioural therapy (iCBT) in addition to treatment as usual (TAU)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Guided Internet- and mobile-based cognitive behavioural therapy (iCBT)
Number of subjects: 212
Study: 36404644

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF) 38% applied for 1 minute
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo (tap water) applied for 1 minute
Number of subjects: 356
Study: 32472526

Group type: EXPERIMENTAL
Intervention: Antiplatelet and anticoagulant therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic nihilism
Number of subjects: 0
Study: 32750310

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (1-SD increment of 14.8 mm Hg)
Number of subjects: 935

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (1-SD increment of 10.7 mm Hg)
Number of subjects: 935
Study: 34431213

Group type: EXPERIMENTAL
Intervention: Propolis mouthwash
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo mouthwash (without propolis)
Number of subjects: 32
Study: 35678032

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) 300 mg with fexofenadine 60 mg and pseudoephedrine 120 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (control) with fexofenadine 60 mg and pseudoephedrine 120 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE)
Number of subjects: 10
Study: 33772998

Group type: EXPERIMENTAL
Intervention: Smart speakers (e.g., Amazon Alexa, Google Home) for about 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no smart speakers)
Number of subjects: 43
Study: 32714972

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscles and transverse abdominal muscle training (PFM + TrA, n=70)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Pelvic floor muscles training alone (PFM, n=70)
Number of subjects: 140
Study: 35938217

Group type: EXPERIMENTAL
Intervention: Nail polish
Number of subjects: 885

Group type: COMPARATOR
Intervention: Polish-free (unpainted nails)
Number of subjects: 885
Study: 35236647

Group type: EXPERIMENTAL
Intervention: Cisplatin plus nab-paclitaxel
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control: nab-paclitaxel
Number of subjects: 44
Study: 34472895

Group type: EXPERIMENTAL
Intervention: SHED-IT: Recharge (self-guided eHealth program)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 125
Study: 32913029

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (32°C-34°C for 24 hours) plus standard care
Number of subjects: 270

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Age >65 years
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Refractory convulsive status epilepticus
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Primary brain insult
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: No bystander-witnessed seizure onset
Number of subjects: 270
Study: 35674757

Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Vehicle group
Number of subjects: 29
Study: 33255353

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet intervention (self-sustained for 6 months)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mediterranean Diet intervention (active for 6 months)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet intervention
Number of subjects: 48
Study: 32185590

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One trabecular micro-bypass stent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two trabecular micro-bypass stents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intracanalicular scaffold
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two trabecular micro-bypass stents with cataract surgery
Number of subjects: 0
Study: 33220090

Group type: EXPERIMENTAL
Intervention: Transcrestal sinus floor elevation (TSFE) with bovine‐derived xenograft and implant placement
Number of subjects: 41

Group type: COMPARATOR
Intervention: Lateral sinus floor elevation (LSFE) with bovine‐derived xenograft and implant placement
Number of subjects: 41
Study: 35913699

Group type: EXPERIMENTAL
Intervention: VIPP-PRE intervention
Number of subjects: 2
Study: 34002326

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: BFR + Electric Muscle Stimulation (EMS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control
Number of subjects: 31
Study: 35387494

Group type: EXPERIMENTAL
Intervention: Sitting Tai Chi
Number of subjects: 80
Study: 33500356

Group type: EXPERIMENTAL
Intervention: IGV-001
Number of subjects: 33

Group type: COMPARATOR
Intervention: SOC (standard of care)
Number of subjects: 33
Study: 35122614

Group type: EXPERIMENTAL
Intervention: Topical triamcinolone 0.1% ointment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Topical mechlorethamine/chlormethine gel alone
Number of subjects: 28
Study: 36495879

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan 5.4 mg/kg
Number of subjects: 524

Group type: COMPARATOR
Intervention: Trastuzumab emtansine 3.6 mg/kg
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Number of subjects: 524

Group type: COMPARATOR
Intervention: Trastuzumab emtansine
Number of subjects: 524
Study: 33587901

Group type: EXPERIMENTAL
Intervention: Blue-blocking spectacles
Number of subjects: 120

Group type: COMPARATOR
Intervention: Clear (placebo) spectacles
Number of subjects: 120
Study: 36471429

Group type: EXPERIMENTAL
Intervention: Postoperative oral administration of cephalexin and metronidazole
Number of subjects: 210
Study: 32576043

Group type: EXPERIMENTAL
Intervention: Endocrinologists
Number of subjects: 359

Group type: COMPARATOR
Intervention: General screening practices
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Factors leading to screening
Number of subjects: 359
Study: 32701204

Group type: EXPERIMENTAL
Intervention: Acute CSC
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Chronic CSC
Number of subjects: 80

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 80
Study: 32274746

Group type: EXPERIMENTAL
Intervention: Scoring balloon angioplasty (SBA) prior to drug-coated balloon angioplasty (DCB)
Number of subjects: 481
Study: 33806669

Group type: EXPERIMENTAL
Intervention: Heat acclimation with permissive dehydration (DEH)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Euhydration (EUH)
Number of subjects: 14
Study: 34001097

Group type: EXPERIMENTAL
Intervention: Equilibrator Series II (Eptamed)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Occlus‐o‐Guide (Sweden & Martina)
Number of subjects: 60
Study: 33207242

Group type: EXPERIMENTAL
Intervention: Anodal transpinal direct current stimulation (tsDCS) combined with language training
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham transpinal direct current stimulation (tsDCS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) combined with the same language treatment
Number of subjects: 10
Study: 32779506

Group type: EXPERIMENTAL
Intervention: Illiteracy
Number of subjects: 3861

Group type: COMPARATOR
Intervention: Lowest education level
Number of subjects: 3861
Study: 35277995

Group type: EXPERIMENTAL
Intervention: TAK-041
Number of subjects: 0
Study: 34153272

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 4806

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4806
Study: 33742271

Group type: EXPERIMENTAL
Intervention: Home-based self-regulated training (HSRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Centralized instructor-regulated training (CIRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both HSRT and CIRT
Number of subjects: 0
Study: 34307977

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 741

Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 741
Study: 36364764

Group type: EXPERIMENTAL
Intervention: Leucine-rich protein powder
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Leucine-rich protein and Placebo)
Number of subjects: 50
Study: 34684498

Group type: EXPERIMENTAL
Intervention: Low-sodium high-potassium seasonings and processed foods
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (standard sodium and potassium content)
Number of subjects: 187
Study: 32215674

Group type: EXPERIMENTAL
Intervention: r-ESWT (2000 pulses of shockwave at 2.0 to 3.0 bar weekly for three weeks)
Number of subjects: 104

Group type: COMPARATOR
Intervention: sham-ESWT
Number of subjects: 104
Study: 36372069

Group type: EXPERIMENTAL
Intervention: 10 mg dapagliflozin
Number of subjects: 6263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study: 32470486

Group type: EXPERIMENTAL
Intervention: Ruxolitinib plus standard-of-care treatment
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo based on standard-of-care treatment
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 34468591

Group type: EXPERIMENTAL
Intervention: Split Workout Routine (n=35)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Full-Body Workout Routine (n=32)
Number of subjects: 67
Study: 32032137

Group type: EXPERIMENTAL
Intervention: Nicotine inhalers
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 310
Study: 34280363

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 623

Group type: COMPARATOR
Intervention: Control group (no cataract surgery)
Number of subjects: 623
Study: 33290975

Group type: EXPERIMENTAL
Intervention: MRI-based radiomics features for LNM prediction
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: MRI-based radiomics features for VEGF prediction
Number of subjects: 163
Study: 35396709

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 93

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 93
Study: 34110707

Group type: EXPERIMENTAL
Intervention: Astaxanthin (AX)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 42
Study: 36400597

Group type: EXPERIMENTAL
Intervention: Flutamide (125 mg orally daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34313697

Group type: EXPERIMENTAL
Intervention: Systemic hydrocortisone treatment initiated 7 to 14 days after birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32217498

Group type: EXPERIMENTAL
Intervention: Tablet-based TSN app prototype
Number of subjects: 299

Group type: COMPARATOR
Intervention: Conventional self-managing control group
Number of subjects: 299
Study: 36104443

Group type: EXPERIMENTAL
Intervention: Oral alfacalcidol
Number of subjects: 976

Group type: COMPARATOR
Intervention: No vitamin D receptor activators
Number of subjects: 976
Study: 33144157

Group type: EXPERIMENTAL
Intervention: Higher adiponectin levels (per 5-µg/ml increase)
Number of subjects: 1641
Study: 33009898

Group type: EXPERIMENTAL
Intervention: Direct anterior approach
Number of subjects: 55

Group type: COMPARATOR
Intervention: Posterior approach
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 55
Study: 35896688

Group type: EXPERIMENTAL
Intervention: Focused low‐intensity pulsed ultrasound (FLIPUS)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Pulsed shortwave diathermy (PSWD)
Number of subjects: 114
Study: 35807858

Group type: EXPERIMENTAL
Intervention: 500 mL of carbonated water plus two kiwifruit (intervention)
Number of subjects: 43

Group type: COMPARATOR
Intervention: 500 mL of carbonated water (control)
Number of subjects: 43
Study: 32627264

Group type: EXPERIMENTAL
Intervention: Contact force–guided radiofrequency (CF‐RF) ablation
Number of subjects: 346

Group type: COMPARATOR
Intervention: Cryoballoon ablation
Number of subjects: 346
Study: 35914738

Group type: EXPERIMENTAL
Intervention: Multi-component, system-level intervention including parent reminders, provider training, clinic-level audit and feedback, workflow modifications
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Multi-component, system-level intervention
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 15000
Study: 33356730

Group type: EXPERIMENTAL
Intervention: Cessation of aspirin at 1 month with continued ticagrelor monotherapy for 23 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cessation of ticagrelor at 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: TRAP-induced PA
Number of subjects: 0
Study: 32538550

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla‐300)
Number of subjects: 3304

Group type: COMPARATOR
Intervention: Standard‐of‐care basal insulin analogues (SOC‐BI)
Number of subjects: 3304